Vascular Diseases, Peripheral
5
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD
Comparative Clinical Efficacy Between Multi-layer Bandage Pressure Therapy and Gradient Pressure Elastic Stocking Treatment After Endovenous Radiofrequency Ablation
The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy
Safety and Efficacy Study of Endovenous Microwave Ablation for Treatment of Varicose Veins
FLUENCY® PLUS in the Treatment of Peripheral Artery Disease